Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
Abroad (travel likely)RecruitingPHASE2
Conditions
Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Adverum site 124, Deerfield Beach, Florida, United States
Adverum site 176, Fort Lauderdale, Florida, United States
Adverum site 168, Jacksonville, Florida, United States
Adverum site 122, West Columbia, South Carolina, United States
Study leads
Adam Turpcu, PhD
Study Director
Adverum Biotechnologies, Inc.